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In recent years, public health genomics has been introduced
in the scientific literature as a new endeavour, aiming at the
translation of genome-based knowledge and technologies
into health interventions and public policies for the benefit
of public health (Brand and Brand 2006; Zimmern and
Stewart 2006; Gwinn and Khoury 2006). In 2009, Public
Health Genomics started to appear as an international
journal and a new signpost of the emerging field; however,
as the editors pointed out, the new journal builds on an
earlier version which was already founded in 1998,
published as Community Genetics (Knoppers and Brand
2009). Thus, as a new and emerging field, public health
genomics does not only embody promises and expectations
for the future. It is also rooted in a history of past attempts
and achievements, constituting “community genetics” as a
bridge between genetics and public health (ten Kate 2005).
In this context the relationship between public health
genomics and community genetics has become a matter of
debate. As becomes clear from the establishment of the new
Journal of Community Genetics, there is a continuing
interest in community genetics, defined by aims independent
from public health genomics. In an interesting sociological
commentary in the first issue of this journal, it is indeed
observed that we should not take for granted that “public
health genetics and community genetics could be viewed as
one and the same” (Raz 2010). In a farewell editorial,
published in the final issue of the former journal Community
Genetics, Leo ten Kate likewise emphasized that community
genetics “is not just a name but a unique concept, which has
its own place besides clinical genetics and public health
genetics or genomics” (ten Kate 2008, see also Schmidtke
and ten Kate 2010;a n dt e nK a t ee ta l .2010).
In this commentary, I will take a closer look at the
uniqueness of the concept of community genetics, using the
11 volumes of the former journal Community Genetics as
my primary source material.
1 My aim is not a complete
review of the contents of this journal, which would be an
impossible task, but a discussion of some aspects and
questions which I see as particularly interesting and
significant for our understanding of the concept and agenda
of community genetics. What can we learn from the history
contained in this former journal about the particularities of
community genetics and its relation with the emerging field
of public health genomics? Most revealing in this history is
the tension between a conception of community genetics as
a professional and regulated endeavour and as a programme
of individual empowerment. Although we can see this
tension as a unique feature following from the concept and
agenda of community genetics, it is also highly significant,
as I will argue, for the future prospects of public health
genomics.
The agenda of community genetics
The ambitions of community genetics as a field can be
defined in terms of four movements or shifts which
characterize the activities of its practitioners as distinct
from the traditional practices of clinical geneticists (ten
Kate 1998; Brisson 2000). The first of these movements is
1 The journal Community Genetics started to appear in 1998 and has
been succeeded in 2009 by the journal Public Health Genomics.I n
total, 11 volumes have been published, including 46 issues.
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Implied by this movement is a shift from people with
symptoms to people without symptoms, whereby the
initiative is coming from the care system. The third
movement is a shift from reproductive choice as a main
focus to options for prevention of disease, and, in relation
to this movement, we might also mention a fourth shift,
from rare monogenetic disorders to multi-factorial forms of
common diseases. This latter shift, however, seems at
present more a prospect than reality (ten Kate 2001; Brand
et al. 2006).
Although the first two shifts are clearly defining the
agenda of community genetics, it is the third shift—from
reproductive choice to prevention of disease—which brings
us to a question that is most revealing and significant for
the ambitions of the field. Traditionally, reproductive choice
has been a major focus of clinical genetic services and
community genetics, likewise, has its roots in population
carrier screening programmes offering reproductive choice
(Modell and Kuliev 1998). Accordingly, in the volumes of
Community Genetics we see a continuing interest in
developments of carrier screening and prenatal screening.
Community genetics, however, is also clearly inspired by
notions of public health, aiming at health promotion and
prevention of disease. Thus, as some authors in the field
have argued, programmes offering reproductive choice
should not be part of the community genetics agenda
because the aims of such programmes cannot and should
not be understood in terms of prevention (Khoury et al.
2000; Holzman 2006). In the journal Community Genetics,
a tension between the aims of prevention and reproductive
choice has indeed been noted as a point of discussion and
concern (Nordgren 1998; Lippman 2001), but more
importantly, the journal has also been instrumental in
attempts to reconcile these different aims by emphasizing
informed choice as a key concept in community genetics
(ten Kate 1999, 2000, 2005; Henneman et al. 2001). This
principle is of crucial importance, as I will argue, for our
understanding of the impact of community genetics in
society.
An examination of the variety of practices that are
discussed in Community Genetics again reveals that the
aims of the field do not correspond in any straightforward
way to a public health agenda in a strict sense. The
practices described in the different volumes should not be
understood just in terms of traditional public health aims,
but rather as a new way of working which involves the
system of health care as a whole. Thus, we find not only
discussions about the ways in which advances in genetics
may be integrated in public health. We also find discussions
about genetic service provision in clinical care, focussing
on common diseases like cancer and heart disease, and as
the most important subject, we find quite a lot of papers
about ways in which genetics relates to practices and
perspectives in primary care.
2
The new way of working that is promoted by community
genetics can be defined as involving the identification of
genetic risk groups in the community. In this approach,
individuals who may not be aware of being at risk can be
offered information about their genetic status and potential
options for prevention. This way of working indeed marks
some of the more salient shifts characterizing the ambitions
and activities of community genetics. Instead of waiting for
people coming with complaints to the consultancy room,
individuals now have to be actively approached by
professionals in the care system (ten Kate 1998). This
brings me to another observation about the contents of the
first 11 volumes of Community Genetics. It is interesting
and significant that a large share of the papers published in
the journal is devoted to questions relating to the users that
community genetics should serve.
3 Obviously, because
individuals are targeted without symptoms or complaints,
the needs, experiences and wishes of these prospective
users have become a highly relevant concern for the
proponents of community genetics. Again, this is a point
of crucial importance for our understanding of the future
impact of the field.
Future prospects of community genetics
Taking these observations as a starting point, I will now
consider two possible scenarios as potentially relevant futures
for community genetics. The future that is implied in the
agenda of community genetics, obviously, isa futurein which
it is the health care system through which new applications of
genetic knowledge are made available to individuals in the
population in an ‘evidence-based’ way (Blancquaert 2000;
Baird 2001; Gwinn and Khoury 2006). Accordingly, it is the
professional who should decide for whom particular appli-
cations might be needed and useful; however, in discussing
the role of community genetics in society, several authors
also refer to the possibility of another future scenario. In this
scenario, genetic tests are becoming more easily available
through commercial providers offering their products on the
market direct to ‘consumers’ who are willing to pay for it
2 As a rough estimate, we can say that of the 430 items that appeared
in Community Genetics from 1998 to 2009, 8% was explicitly devoted
to the role of genetics in public health, 5% to genetics in clinical care
and 7% to genetics in primary care. Not included in these figures are
the items focusing on genetics in reproductive care (13% of the total
number). See also ten Kate (2007) for an overview of the contents of
the first nine volumes.
3 Indeed, of all the 435 items mentioned in note 2, 14% explicitly
focused on the variety of users in terms of particular risk groups,
minorities or communities to be served by community genetics.
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view of community genetics, this prospect is clearly seen as
a threat that has to be averted by sound policies of regulation
(Ronchi et al. 2000; Guillod 2000;H o l z m a n2006).
Community genetics, in other words, will have to be
developedin a societallandscape offering a variety of contexts
in which applications of genetic knowledge may become
availabletofutureusers,bothinsideandoutsidethehealthcare
system. One element in this landscape which will shape future
applications is governmental regulation. Another element is
the growth of commercial services, offering genetic tests on an
international scale through the internet. What is the relevance
of these observations for our understanding of the future
impact of community genetics? There are two points which I
see as most important here, one of which goes down to the
heart of community genetics itself. The first point is that it will
be very difficult, if not impossible, to resist by governmental
regulation a growing commercialisation of genetic services on
a global scale. Moreover, and this is my second point, a
scenario like this will become all the more probable in a world
governed by a principle of informed choice, the very principle
adopted by community genetics as its key concept.
Community genetics, we may say, is based on an
individual rights perspective, emphasizing autonomy and
self-determination as fundamental values. Traditionally,
individual rights have been conceived as a way to protect
individuals against interventions—medical or otherwise—
that may be harmful or unwanted, but as we may learn from
the contents of Community Genetics, individual rights can be
understood in terms of empowerment as well. Thus,
empowerment has been intimated in the journal as serving
the aim of equal access to services, information and choices
for individuals from diverse communities. In a world where
respect for individual autonomy is not universally accepted
and where we find many disadvantaged populations and
communities, both protection and empowerment are of
course highly relevant concerns (Wertz and Fletcher 2004),
but as observed in Community Genetics, in a particularly
thought-provoking contribution, the notion of empowerment
may also take on a different, more radical and problematic
meaning (Caulfield and Wertz 2001). In this guise, it serves
as a perceived right of access to services for everyone who—
for whatever reasons—might want to. From this perspective,
reasoned attempts to restrict access or protect individuals
may easily be branded as paternalism. Needless to say, this
notion of empowerment fits nicely with the aims of
commercial providers of genetic tests (Parthasarathy 2003).
A tension between regulation and empowerment
Let me sum up at this point what I see as some of the more
striking issues emerging from the first 11 volumes of
Community Genetics. In my discussion, I focused on the
agenda of community genetics involving a quite complex
picture of a broadly conceived entrenchment of genetics in
the system of health care. I added to this picture some
observations about the societal landscape in which this
agenda will have to be realised. From this picture emerged
an important tension between regulation of health care
services on one hand and empowerment of individual
health consumers on the other. This tension not only
characterizes our modern health care landscape. It is also
manifested in the community genetics agenda itself,
revealing a clear ambivalence between community genetics
as a professional and regulated endeavour and as a
programme of individual empowerment. Another, interesting
andsignificantmanifestationofthisambivalence isthewayin
which prospective users are represented in the volumes of
Community Genetics. As I noted, the needs and wishes of
users appear in the journal as a highly relevant concern, but
what is most revealing in this respect are the various ways in
which users are defined, ranging from patients (Emery et al.
1998) to publics (Henneman et al. 2004), citizens (Godard et
al.2007), clients (Detmar et al. 2008) and, indeed, consumers
(Terry and Davidson 2000).
What about public health genomics?
The starting point of my commentary and the exploration of
the contents of the journal Community Genetics was the
question of the uniqueness of the concept of community
genetics, especially in relation to public health genomics as
an emerging field. One way to understand this uniqueness
is in terms of the origin of the field. Community genetics
has been positioned as a bridge between clinical genetics
and public health (ten Kate 2005). In other words,
community genetics is rooted in a tradition of individual
care embodied in clinical genetics, and it shares with this
tradition informed choice and individual empowerment as
the major aims of the field. In this respect, community
genetics may be contrasted to public health genomics, even
though both fields share the aim of integrating genetics in
public health. Firmly rooted in a public health tradition,
public health genomics emphasizes the improvement of
population health as its key objective. Indeed, the focus on
health from a population perspective is exactly the reason
why proponents of the field prefer to name it ‘public health
genomics’ instead of ‘community genetics’ (Knoppers and
Brand 2009).
In adopting informed choice as a key concept, community
genetics not only distinguishes itself from public health
genomics, but it also highlights an important tension between
professional regulation and individual empowerment; how-
ever, in this latter respect, community genetics involves a
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of the future prospects of public health genomics. Moving
from opposite starting points, community genetics and public
healthgenomics,inacommonendeavourtointegrategenetics
into public health, to some extent are heading for a similar
approach. I have described the agenda of community genetics
in terms of different movements, including a shift in focus
awayfromindividualstopopulations.Insimilarterms,wecan
describe the programme of public health genomics as a
movement from the population level to a more individualised
approach. Thus, it is stated as the “holy grail” of public health
genomics that, based on a fuller understanding of genetic and
environmental factors involved in the causation of disease, it
will be possible to devise effective preventive interventions
targeted at individuals with specific genotypes (Zimmern and
Stewart 2006). In other words, instead of the traditional “one
size fits all” stance underlying whole-population strategies in
public health, public health genomics promises a more
nuanced approach that incorporates differences in individual
susceptibility as opportunities for individualised prevention
(Bellagio report 2005). Accordingly, we can observe that in
public health genomics too, personal responsibility and
empowerment are promoted as final objectives, making
public health eventually the result of individual decisions of
citizens (Laberge 2002).
Another more obvious point, on which community
genetics and public health genomics agree, is the belief
that genome-based information or interventions should be
introduced only in an ‘evidence-based’ way. In this regard,
the endeavour of public health genomics obviously also
involves a potential tension between the aim of evidence-
based interventions and a focus on individual decision
making and personal responsibility. Compared to commu-
nity genetics, this tension may become even more chal-
lenging because in public health genomics, as authors about
the field contend, “it may be several decades before the
scientific basis for the ‘predict and prevent’ scenario can be
adequately evaluated” (Stewart et al. 2007). In other words,
the so-called “translation highway” of genomics in public
health appears to be a long and winding road to a distant
and uncertain future (Gwinn and Khoury 2006; Khoury et
al. 2007 and 2008). In this context of high expectations and
major uncertainties, the more immediate future of public
health genomics will not be shaped by evidence-based
professional strategies of personalised prevention, but will
primarily depend on the initiatives of commercial providers
of genetic information and, of course, on the appeal of their
services to individual health consumers. In this context, we
may also expect ongoing conflict between those developing
new genome-based technologies for the health care market
and those who have to evaluate these technologies from an
evidence-based public health point of view (Woodcock
2008).
Facing the challenge
In my account in this commentary of the concept and
agenda of community genetics, I have revealed a tension
which also points to an important future challenge for the
emerging field of public health genomics. Is there anything
for us to learn from the experiences in the field of
community genetics that might suggest ways to bridge
potential conflicts between policies of regulation and the
empowerment of individual users? This seems to me a most
interesting and critical question for community genetics in
the future.
Acknowledgement This commentary is the result of a research
project of the Centre for Society and Genomics in The Netherlands,
funded by the Netherlands Genomics Initiative. I thank Pauline
Fransen for her contribution to this project.
Open Access This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
Baird PA (2001) Current challenges to appropriate clinical use of new
genetic knowledge in different countries. Community Genet
4:12–17
Bellagio report (2005) Genome-based research and population health.
Report of an expert workshop held at the Rockefeller Foundation
Study and Conference Centre, Bellagio, Italy, 14–20 April 2005
Blancquaert I (2000) Availability of genetic services: implementation
and policy issues. Community Genet 3:179–183
Brand A, Brand H (2006) Public health genomics—relevance of
genomics for individual health information management, health
policy development and effective health services. Ital J Pub
Health 3(3–4):24–34
Brand A, Schröder P, Brand H, Zimmern R (2006) Getting ready for
the future: integration of genomics in public health research,
policy and practice in Europe and globally. Community Genet
9:67–71
Brisson D (2000) Analysis and integration of definitions of community
genetics. Community Genet 3:99–101
Caulfield T, Wertz D (2001) Creating needs? Community Genet 4:68–76
Detmar S, Dijkstra N, Nijsingh N, Rijnders M, Verweij M, Hosli E
(2008) Parental opinions about the expansion of the neonatal
screening programme. Community Genet 11:11–17
Emery J, Kumar S, Smith H (1998) Patient understanding of genetic
principles and their expectations of genetic services within the
NHS: a qualitative study. Community Genet 1:78
Godard B, Marshall J, Laberge C (2007) Community engagement in
genetic research: results of the first public consultation for the
Quebec CARTaGENE project. Community Genet 10:147–158
Guillod O (2000) Access to genetic tests: a legal perspective.
Community Genet 3:221–224
Gwinn M, Khoury MJ (2006) Genomics and public health in the
United States: signposts on the translation highway. Community
Genet 9:21–26
Henneman L, Langendam MW, ten Kate LP (2001) Community
genetics and its evaluation: a European Science Foundation
workshop. Community Genet 4:56–59
198 J Community Genet (2010) 1:195–199Henneman L, Timmermans DRM, van der Wal G (2004) Public
experiences, knowledge and expectations about medical genetics
and the use of genetic information. Community Genet 7:33–43
Holzman NA (1998) The UK’s policy on genetic testing services
supplied direct to the public—two spheres and two tiers.
Community Genet 1:49–52
Holzman NA (2006) What role for public health in genetics and vice
versa? Community Genet 9:8–20
Khoury MJ, Burke W, Thomson EJ (2000) Genetics and public health: a
framework for the integration of human genetics into public health
practice. In: Khoury MJ, Burke W, Thomson EJ (eds) Genetics and
public health in the 21st century. Using genetic information to
improvehealthandpreventdisease,Oxfordmonographsonmedical
genetics, vol. 40. Oxford University Press, Oxford
Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L
(2007) The continuum of translation research in genomic medicine:
howcan weacceleratetheappropriate integrationofhumangenome
discoveries into health care and disease prevention? Genet Med 9
(10):665–674
Khoury MJ, Berg A, Coates R, Evans J, Teutsch SM, Bradley LA
(2008) The evidence dilemma in genomic medicine. Health Aff
27(6):1600–1611
Knoppers BM, Brand A (2009) From community genetics to public
health genomics—what’s in a name? Pub Health Genom 12:1–3
Laberge C (2002) Genomics, health and society. In: Knoppers BM,
Scriver Ch (eds) Genomics, health and society. Emerging issues
for public policy. Policy Research Initiative, Canada
Lippman A (2001) Bottom line genetics. Community Genet 4:87–89,
followed by discussion between Cuckle H and Lippman A,
4:173–174
Modell B, Kuliev A (1998) The history of community genetics: the
contribution of the haemoglobin disorders. Community Genet 1:3–11
Nordgren A (1998) Reprogenetics policy: three kinds of models.
Community Genet 1:61–70
Parthasarathy S (2003) Knowledge is power: genetic testing for breast
cancer and patient activism in the United States and Britain. In:
Oudshoorn N, Pinch T (eds) How users matter. The co-construction
of users and technologies. MIT, Cambridge
Raz AE (2010) Commentary: a sociologist’s view on community
genetics. J Community Genet 1(1):3–10
Ronchi E, Harper D, Taylor A, Haslberger AG (2000) Genetic testing:
policy issues for the new millennium. Community Genet 3:161–
163
Schmidtke J, ten Kate LP (2010) The journal of community genetics. J
Community Genet 1(1):1–2
Stewart A, Brice Ph, Burton H, Pharoah P, Sanderson S, Zimmern R
(2007) Genetics, health care and public policy. An introduction to
public health genetics. Cambridge University Press, Cambridge
ten Kate LP (1998) Editorial. Community Genet 1:1
ten Kate LP (1999) Editorial. Community Genet 2:1
ten Kate LP (2000) Editorial. Community Genet 3:1
ten Kate LP (2001) Editorial. Community Genet 4:1
ten Kate LP (2005) Community genetics: a bridge between clinical
genetics and public health. Community Genet 8:7–11
ten Kate LP (2007) From milestone to moral obligation. Community
Genet 10:1
ten Kate LP (2008) Discharge and farewell. Community Genet 11:312
ten Kate LP et al (2010) Community genetics: its definition 2010. J
Community Genet 1(1):19–22
Terry SF, Davidson ME (2000) Empowering the public to be informed
consumers of genetic technologies and services. Community
Genet 3:148–150
Wertz DC, Fletcher JC (2004) Genetics and ethics in global
perspective. Kluwer, Dordrecht
Williams-Jones B (2003) Where there’s a web, there’s a way:
commercial genetic testing and the internet. Community Genet
6:46–57
Woodcock J (2008) Perspective. The human genome and translational
research: how much evidence is enough? Health Aff 27(6):1616–
1618
Zimmern R, Stewart A (2006) Public health genomics: origins and
basic concepts. Ital J Pub Health 3(3–4):9–15
J Community Genet (2010) 1:195–199 199